Phase I Study of Palomid 529 a Dual TORC1/2 Inhibitor of the PI3K/Akt/mTOR Pathway for Advanced Neovascular Age-Related Macular Degeneration (P52901)

Clinical Trial ID NCT01033721

PubWeight™ 5.07^‹?›

🔗 Visit the ClinicalTrials.gov page for NCT01033721

Top papers